Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alagille syndrome case series: five new variants and two large deletions.

European journal of pediatrics·2026
Same author

Evaluation of temperament and behavioral characteristics in preschool children with dermatological diseases.

Cutaneous and ocular toxicology·2026
Same author

Evaluation of large language models in terms of safety, contraindications, and adverse effect information related to botulinum toxin applications.

Cutaneous and ocular toxicology·2026
Same author

Escin Attenuates Amyloid Beta 1-42-Induced Oxidative Stress, Apoptosis, and Neuroinflammation in Neuron-Like SH-SY5Y Cells.

Journal of biochemical and molecular toxicology·2026
Same author

Comment on 'Recurrent morphoeic basal cell carcinoma with metastatic progression in a 34-years-old patient: a case report'.

Clinical and experimental dermatology·2026
Same author

Psychiatric comorbidity and its impact on biological treatment in hidradenitis suppurativa: A commentary based on current data.

Journal of the American Academy of Dermatology·2026

Related Experiment Video

Updated: Jan 11, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.4K

GRWD1 Drives Melanoma Growth Through NF-κB Signaling Pathway.

Dursun Turkmen1, Rafet Ozbey2, Berna Ozdem3

  • 1Department of Dermatology, Faculty of Medicine, Inonu University, Malatya, Türkiye.

Dermatology Practical & Conceptual
|November 14, 2025
PubMed
Summary

Knocking down the GRWD1 protein significantly inhibits melanoma cell growth, migration, and enhances apoptosis. High GRWD1 expression correlates with poor survival in metastatic melanoma patients, suggesting its potential as a therapeutic target.

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.5K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.4K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.5K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Melanoma is an aggressive skin cancer with a high potential for metastasis.
  • The role of the oncogenic protein GRWD1 in melanoma progression was previously unclear.

Purpose of the Study:

  • To investigate the impact of GRWD1 knockdown on melanoma cell behaviors, including proliferation, apoptosis, and migration.
  • To assess the prognostic significance of GRWD1 expression in melanoma patients.

Main Methods:

  • In vitro studies involved GRWD1 knockdown in A2058 melanoma cells using siRNA, followed by proliferation, apoptosis, and migration assays.
  • Western blotting analyzed key oncogenic pathway alterations.
  • Clinical analysis included GRWD1 expression assessment in patient samples and survival analysis using Kaplan-Meier methods.

Main Results:

  • GRWD1 knockdown reduced melanoma cell proliferation by 63% and migration by 70%, while inducing apoptosis.
  • Suppression of NF-κB pathway activity was observed, affecting downstream targets like Bcl-2, Src, and MDM2, and stabilizing p53.
  • High GRWD1 expression in public datasets (TCGA) correlated with shorter survival in metastatic melanoma (P=0.00029), but clinical sample analysis showed no significant survival correlation.

Conclusions:

  • GRWD1 is crucial for melanoma progression, promoting proliferation and migration via NF-κB pathway activation.
  • GRWD1 represents a potential therapeutic target for melanoma.
  • Further clinical validation is required to confirm GRWD1's prognostic utility in melanoma.